Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States.
Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States.
复制标题
DOI:
10.3201/eid2801.212220
复制
发表时间:
2022-01
影响因子:
11.8
通讯作者:
Laney AS
中科院分区:
文献类型:
--
作者:
Gharpure R;Sami S;Vostok J;Johnson H;Hall N;Foreman A;Sabo RT;Schubert PL;Shephard H;Brown VR;Brumfield B;Ricaldi JN;Conley AB;Zielinski L;Malec L;Newman AP;Chang M;Finn LE;Stainken C;Mangla AT;Eteme P;Wieck M;Green A;Edmundson A;Reichbind D;Brown V Jr;Quiñones L;Longenberger A;Hess E;Gumke M;Manion A;Thomas H;Barrios CA;Koczwara A;Williams TW;Pearlowitz M;Assoumou M;Senisse Pajares AF;Dishman H;Schardin C;Wang X;Stephens K;Moss NS;Singh G;Feaster C;Webb LM;Krueger A;Dickerson K;Dewart C;Barbeau B;Salmanson A;Madoff LC;Villanueva JM;Brown CM;Laney AS
During July 2021, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.617.2 variant infections, including vaccine breakthrough infections, occurred after large public gatherings in Provincetown, Massachusetts, USA, prompting a multistate investigation. Public health departments identified primary and secondary cases by using coronavirus disease surveillance data, case investigations, and contact tracing. A primary case was defined as SARS-CoV-2 detected <14 days after travel to or residence in Provincetown during July 3–17. A secondary case was defined as SARS-CoV-2 detected <14 days after close contact with a person who had a primary case but without travel to or residence in Provincetown during July 3–August 10. We identified 1,098 primary cases and 30 secondary cases associated with 26 primary cases among fully and non–fully vaccinated persons. Large gatherings can have widespread effects on SARS-CoV-2 transmission, and fully vaccinated persons should take precautions, such as masking, to prevent SARS-CoV-2 transmission, particularly during substantial or high transmission.
登录
查看更多内容
DOI:
10.1016/s1473-3099(21)00460-6
发表时间:
2022-01
期刊:
The Lancet. Infectious diseases
影响因子:
--
作者:
Antonelli M;Penfold RS;Merino J;Sudre CH;Molteni E;Berry S;Canas LS;Graham MS;Klaser K;Modat M;Murray B;Kerfoot E;Chen L;Deng J;Österdahl MF;Cheetham NJ;Drew DA;Nguyen LH;Pujol JC;Hu C;Selvachandran S;Polidori L;May A;Wolf J;Chan AT;Hammers A;Duncan EL;Spector TD;Ourselin S;Steves CJ
通讯作者:
Steves CJ
DOI:
10.1016/s0140-6736(21)02183-8
发表时间:
2021-10-16
期刊:
Lancet (London, England)
影响因子:
--
作者:
Tartof SY;Slezak JM;Fischer H;Hong V;Ackerson BK;Ranasinghe ON;Frankland TB;Ogun OA;Zamparo JM;Gray S;Valluri SR;Pan K;Angulo FJ;Jodar L;McLaughlin JM
通讯作者:
McLaughlin JM
DOI:
10.15585/mmwr.mm7030e2
发表时间:
2021-07-27
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Christie A;Brooks JT;Hicks LA;Sauber-Schatz EK;Yoder JS;Honein MA;CDC COVID-19 Response Team
通讯作者:
CDC COVID-19 Response Team
DOI:
10.1016/s1473-3099(21)00648-4
发表时间:
2022-03
期刊:
The Lancet. Infectious diseases
影响因子:
--
作者:
Singanayagam A;Hakki S;Dunning J;Madon KJ;Crone MA;Koycheva A;Derqui-Fernandez N;Barnett JL;Whitfield MG;Varro R;Charlett A;Kundu R;Fenn J;Cutajar J;Quinn V;Conibear E;Barclay W;Freemont PS;Taylor GP;Ahmad S;Zambon M;Ferguson NM;Lalvani A;ATACCC Study Investigators
通讯作者:
ATACCC Study Investigators
DOI:
10.2807/1560-7917.es.2021.26.30.2100636
发表时间:
2021-07
期刊:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
影响因子:
--
作者:
Hetemäki I;Kääriäinen S;Alho P;Mikkola J;Savolainen-Kopra C;Ikonen N;Nohynek H;Lyytikäinen O
通讯作者:
Lyytikäinen O